Literature DB >> 6251986

Sphingomyelinase activities of various human tissues in control subjects and in Niemann-Pick disease - development and evaluation of a microprocedure.

M T Vanier, A Revol, M Fichet.   

Abstract

A micromethod was elaborated for the assay of sphingomyelinase activities with native labelled substrate in leukocytes, cultivated skin fibroblasts, liver tissue and cultivated amniotic fluid cells. The optimal assay conditions and specific activities in control samples were investigated for each enzyme souce. No significant difference was found between results obtained either with the micromethod or with our previous procedure. Findings obtained in pathological material from 62 patients with the various forms of Niemann-Pick disease and 21 obligate heterozygotes by one or another method are reported. A generalized severe sphingomyelinase deficiency was observed in all cases with Niemann-Pick disease type A or B, while in Niemann-Pick disease type C, sphingomyelinase activities were normal in leukocytes, elevated in liver tissue and partially deficient in cultivated skin fibroblasts. Six pregnancies at risk were monitored.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6251986     DOI: 10.1016/0009-8981(80)90309-5

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  13 in total

1.  Critical assessment of chitotriosidase analysis in the rational laboratory diagnosis of children with Gaucher disease and Niemann-Pick disease type A/B and C.

Authors:  Markus Ries; Ellen Schaefer; Till Lührs; Latha Mani; Jana Kuhn; Marie T Vanier; Frank Krummenauer; Andreas Gal; Michael Beck; Eugen Mengel
Journal:  J Inherit Metab Dis       Date:  2006-07-27       Impact factor: 4.982

2.  Late onset Krabbe's leukodystrophy: a report of four cases.

Authors:  M Phelps; J Aicardi; M T Vanier
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-04       Impact factor: 10.154

3.  Effect of u18666a on beta-glucosidase, sphingomyelinase, and beta-galactosidase activities in astrocytes of young rats.

Authors:  Daniela Copetti Santos; Cristina da Silva Garcia; Carla Vieira de Andrade; Vanessa Vitcoski Daitx; Vitória da Costa Moraes; Francieli Rohden; Janice Carneiro Coelho
Journal:  J Membr Biol       Date:  2015-02-17       Impact factor: 1.843

4.  Cirrhosis and liver failure: expanding phenotype of Acid sphingomyelinase-deficient niemann-pick disease in adulthood.

Authors:  Olivier Lidove; Frédéric Sedel; Frédéric Charlotte; Roseline Froissart; Marie T Vanier
Journal:  JIMD Rep       Date:  2014-04-10

Review 5.  Complex lipid trafficking in Niemann-Pick disease type C.

Authors:  Marie T Vanier
Journal:  J Inherit Metab Dis       Date:  2014-11-26       Impact factor: 4.982

6.  Enzyme activities and phospholipid storage patterns in brain and spleen samples from Niemann-Pick disease variants: a comparison of neuropathic and non-neuropathic forms.

Authors:  G T Besley; M Elleder
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

7.  Niemann-Pick disease: lipid storage in bone marrow macrophages.

Authors:  M Elleder; J Hrodek; J Cihula
Journal:  Histochem J       Date:  1983-11

8.  Deletion of arginine (608) in acid sphingomyelinase is the prevalent mutation among Niemann-Pick disease type B patients from northern Africa.

Authors:  M T Vanier; K Ferlinz; R Rousson; S Duthel; P Louisot; K Sandhoff; K Suzuki
Journal:  Hum Genet       Date:  1993-10       Impact factor: 4.132

9.  A family with visceral course of Niemann-Pick disease, macular halo syndrome and low sphingomyelin degradation rate.

Authors:  W Sperl; G Bart; M T Vanier; H Christomanou; I Baldissera; E Steichen-Gersdorf; E Paschke
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

10.  Alterations in cholesterol metabolism in cultured fibroblasts from patients with Niemann-Pick disease type C.

Authors:  C Mazière; J C Mazière; L Mora; A Lageron; C Polonovski; J Polonovski
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.